Plenary Speakers

Dr. Alvin Roth

Craig and Susan McCaw Professor of Economics at Stanford University
The George Gund Professor Emeritus of Economics and Business Administration at Harvard

Session Title: Kidney Exchange: An Opportunity for Cooperation in North America 

Date: Wednesday, October 16, 2019

Time: 4:35 PM - 5:35 PM 

Alvin Roth

Al Roth is the Craig and Susan McCaw Professor of Economics at Stanford University, and the George Gund Professor Emeritus of Economics and Business Administration at Harvard. He shared the 2012 Nobel memorial prize in Economics, “for the theory of stable allocations and the practice of market design". He directed the redesign of the National Resident Matching Program (and the Roth-Peranson algorithm which organizes the NRMP is also used in the Canadian Resident Matching Service). He has also helped in the reorganization of matches for medical fellowships, and in other labor markets. He helped design the high school matching system used in New York City, the matching system used in Boston Public Schools, for students of all ages, and school choice systems in several other large American cities. He is one of the early founders and designers of kidney exchange in the United States, which helps incompatible patient-donor pairs find compatible kidneys for transplantation.

Dr. Jesse Schold,PhD, M.Stat., M.Ed

Department of Quantitative Health Sciences, Director, Center for Populations Health Research, Cleveland Clinic, Cleveland, Ohio

Session Title: Understanding Wait-list Mortality: The Competing Risks of Bypassing an Offer

Date: Thursday, October 17, 2019

Time: 8:00 AM - 9:00 AM

Jesse Schold

Dr. Jesse Schold, PhD, M.Stat., M.Ed. is an Full Staff member in the Department of Quantitative Health Sciences in the Health Outcomes Research and Clinical Epidemiology Section and Director of Outcomes Research in Kidney Transplantation at the Cleveland Clinic in Cleveland, Ohio. He is also currently the Director of the Center for Populations Health Research at the Lerner Research Institute. He received his undergraduate training at Emory University, two Masters degrees at North Carolina State University and a Doctorate at the University of Florida.

Dr. Schold’s research interests include large database analyses, quality metrics for healthcare providers, health services research, disparities in access to healthcare and statistical and epidemiological methods. He oversees outcomes monitoring and quality evaluation of the solid organ transplantation programs at the Cleveland Clinic and has special interest in the development and use of report cards for evaluating the quality of transplant programs.

Dr. Schold has authored over 240 peer-reviewed scientific publications with primary focus in the field of organ transplantation. He has served on numerous national committees and a former Board member of the American Society of Transplantation. Dr. Schold has been a Co-investigator on multiple studies from the National Institutes of Health, Health Services and Resource Administration and the Centers for Disease Control and Prevention. Dr. Schold has given over 160 invited national and international lectures and peer-reviewed abstract presentations at scientific conferences.

Dr. Robert A. Montgomery

MD, D.Phil, FACS, Professor of Surgery, Director, NYU Langone Transplant Institute, NYU Langone Health, New York, NY

Session Title: State-of-the-Art Desensitization: Increasing Acess to Transplant by Willing to Cross Antibodies

Date: Thursday, October 17, 2019

Time: 9:00 AM - 9:30 AM


Robert A. Montgomery, MD, DPhil, FACS, is the Director of the NYU Langone Transplant Institute and a Professor of Surgery. He received his Doctor of Medicine with Honor from the University of Rochester School of Medicine. He received his Doctor of Philosophy from Balliol College, The University of Oxford, England in Molecular Immunology. Montgomery completed his general surgical training, multi-organ transplantation fellowship, and postdoctoral fellowship in Human Molecular Genetics at Johns Hopkins. He is considered a world expert on kidney transplantation for highly sensitized and ABO incompatible patients.

Dr. Christine Durand

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

Session Title: HCV Positive Donors for HCV Negative Recipients: In Whom are the Risks Worth the Benefits?

Date: Thursday, October 17, 2019

Time: 10:30 AM - 10:50 AM

Christine Durand

Christine Durand is an Associate Professor of Medicine at The Johns Hopkins University School of Medicine in the Division of Infectious Disease. Her clinical work and research focuses on outcomes in individuals with HIV and viral hepatitis who require cancer or transplant therapies. She is particularly interested in the use of organs from donors with viral infections as strategy to address the organ shortage.

Dr. Shaf Keshavjee, MD

Surgeon in Chief, Sprott Department of Surgery, UHN, James Wallace McCutcheon Chair in Surgery, Director, Toronto Lung Transplant Program, Director, Latner Thoracic Research Laboratories, Professor, Institute of Biomaterials & Biomedical Engineering, Professor, Division of Thoracic Surgery, Vice Chair, Innovation, Dept. Surgery, University of Toronto.

Session Title: Lung Transplant Outcomes from Marginal Donors

Date: Thursday, October 17, 2019

Time: 11:10 AM - 11:40 AM

Shaf Keshavjee

Shaf Keshavjee is a Thoracic surgeon and Director of the Toronto Lung Transplant Program. He is Surgeon-in-Chief, James Wallace McCutcheon Chair in Surgery at University Health Network. He is a Professor Division of Thoracic Surgery and Institute of Biomaterials and Biomedical Engineering, and Vice Chair for Innovation, Department of Surgery at the University of Toronto.

Dr Keshavjee completed his medical training at the University of Toronto in 1985. He subsequently trained in General Surgery, Cardiac Surgery and Thoracic Surgery at the University of Toronto followed by fellowship training at Harvard University and the University of London for airway surgery and heart-lung transplantation respectively. He joined the faculty at the University of Toronto in 1994 and was promoted to full professor in 2002. Dr. Keshavjee was the inaugural holder of the Pearson-Ginsberg Chair in Thoracic Surgery and served as the Chair of the Division of Thoracic Surgery at the University of Toronto from 2004 to 2010.

Dr Keshavjee’s clinical practice is in thoracic oncology, lung cancer and lung transplantation. He has a passion for surgery and innovative research. He is a senior scientist in the McEwen Center for Regenerative Medicine at the Toronto General Hospital Research Institute. He leads a team of researchers in a foremost research program and is widely published in the field. His specific research interest is in lung injury related to transplantation. His current work involves the study of molecular diagnostics and gene therapy strategies to repair organs and to engineer superior organs for transplantation.

Dr. Keshavjee has served on the board of directors of the International Society for Heart and Lung Transplantation, The Canadian Society of Transplantation and on the Governing Council of the American Association for Thoracic Surgery. He has received numerous awards for contributions to medicine, including the George Armstrong Peters Young Investigator Award, Canada’s Top 40 Under 40 Award, the Colin Woolf Award for Excellence in Medical Education and the Lister Prize in Surgery - the highest award for research achievement in the University of Toronto Department of Surgery. He is a Fellow of the Canadian Academy of Health Sciences and has been awarded an Honorary Doctor of Science Degree from Ryerson University, as well as an Honorary Doctorate of Science from Queen’s University. He received the Lifetime Achievement Award from the Canadian Society for Transplantation for his contributions to the field of lung transplantation. He has also received two Queen Elizabeth II Diamond Jubilee Medals. He was awarded the Order of Ontario and also received Canada’s highest civilian honour with an appointment as an Officer of the Order of Canada.

Dr. Anouar Teriaky, MD, FRCPC

Assistant Professor of Medicine, Division of Gastroenterology, Department of Medicine, Western University, Multi-Organ Transplant Program, London Health Sciences Centre

Session Title: HCV Positive Organ Donors to HCV Negative Recipients: The Canadian Exchange

Date: Thursday, October 17, 2019

Time: 10:50 AM -  11:10 AM 

Anouar Teriaky
Dr. Anouar Teriaky is an Assistant Professor of Medicine at Western University in the Department of Medicine, Division of Gastroenterology and Hepatology. He is a transplant hepatologist in the Multi-Organ Transplant Program at London Health Sciences Centre. He completed his Bachelor of Science with Honours in Biochemistry at the University of Ottawa followed by his MD at the University of Ottawa. He finished his residency in internal medicine and fellowship in gastroenterology at Western University. Dr. Teriaky completed further training in transplant and general hepatology at the University of Chicago Medical Center. He is currently completing his Master of Public Health degree at Harvard University. Research interests include social disparities in liver transplantation and hepatocellular carcinoma.

Dr. Andrew Healey,MD, RDCS, RDMS, FRCPC, (EM CCM)

Chief Medical Officer - Donation, Trillium Gift of Life Network

Andrew Healey

Dr. Healey is a specialist in Emergency and Critical Care Medicine. Currently, he is the Division Head and Medical Director of Critical Care at the William Osler Health System, and Staff Emergency Physician at St. Joseph’s Healthcare Hamilton. Originally from Newfoundland, Dr. Healey has completed fellowship training in emergency medicine, critical care medicine, and echocardiography at McMaster. He also completed a Masters in the donation of organs, tissues, and cells for transplantation at the Universitat de Barcelona, Spain. He is currently the Chief Medical Officer for Donation with Trillium Gift of Life Network. He is principly responsible for the donation arm of the Non-perfused Organ (Lung) Donation Feasibility Study at William Osler Health Services where he practices critical care. He is supported by four wonderful children and an extremely forgiving and understanding wife.

Dr. Richard N. Formica Jr, MD

Richard N. Formica Jr

Dr. Formica graduated from Boston University in 1989 with a degree in chemistry and Boston University School of Medicine in 1993. He trained in internal medicine at the Combined Boston University Internal Medicine Program and served as the last Chief Medical Resident for Boston City Hospital. He then moved to Yale University for his Nephrology Fellowship. Dr. Formica joined the faculty of Yale University School of Medicine in 1999 and currently serves as the Director of Transplant Medicine, the Director of the Outpatient Transplantation Service, the Medical Director of Adult and Pediatric Kidney Transplantation. He is a Professor of Medicine and Surgery at Yale University School of Medicine.

Dr. Formica has academic interests in translational and clinical areas of transplantation research. He serves as a local PI on an NIH sponsored Clinical Trials in Organ Transplantation protocol. In addition he has clinical research interests in process and quality improvement in transplantation. He has authored or co-authored 75 original scientific articles, review articles, internet publications and book chapters.

Dr. Formica has been a member of the AST since 1999 and has served on the Practice Guidelines Committee, the Patient Care and Education Committee, the AST/ASN Renal Transplant Training Accreditation Program Committee and the Public Policy Committee. He became a counselor-at-large in 2014 and assumed the role of secretary in 2017. In this capacity he has served on the CEOT planning committee, the Apol-1 and Hepatitis C consensus conferences planning committee and the Transplant Patient Summit planning committee.

Dr. Formica has served the United Network of Organ Sharing, where he was the Chairman of the Kidney Committee. During his tenure he was intimately involved in the development and implementation of the New Kidney Allocation Policy developing the Kidney Paired Donation Program and chaired the Simultaneous Liver-Kidney Transplant working group. He is current a member of the Membership and Professional Standards Committee. He will assume the role of Associate Regional Councilor for region 1 in July 2019.

He is an avid skier, being an active patroller in the National Ski Patrol, and sailboat racer, having competed in 11 Bermuda Races amongst other off shore and PHRF races. He is also an accomplished amateur stonemason.

Sean M. Delaney, BSc, MPH

Associate Director for Organ Listing & Allocation with Canadian Blood Services / Transplant patient since 1998
Sean Delaney

Sean Delaney is located in Edmonton, Alberta, and has been working as a health administrator for his entire career. He has worked in community-based rehabilitation, managed a reporting & epidemiology division in a large health region, and finally with the Province of Alberta funding provincial services like dialysis, transplantation, and high-cost drugs within the Ministry of Health. Since 2007, he has worked with the Canadian Council for Donation & Transplantation, and for the past 10 years with Canadian Blood Services on the creation of a national collaboration in support of Organ Donation & Transplantation. He was part of building the original Kidney Paired Donation (KPD) program, as well as implementing the HSP kidney sharing program that together have produced over 1000 transplants for Canadian patients through interprovincial sharing. Most recently, he has been working on advancing heart and liver sharing through the Canadian Transplant Registry through policy development and program implementation activities. Since 1998, he has also been a transplant recipient, a generous gift from his brother.

Dr. Emily Blumberg

Professor of Medicine, Perelman School of Medicine at the University of Pennsylvania


Dr. Blumberg is a Professor of Medicine (Infectious Diseases) at the Perelman School of Medicine at the University of Pennsylvania, where she is the Director of Transplant Infectious Diseases and the Infectious Diseases Fellowship Program Director. Her research focuses on donor derived infections and viral infections in transplant recipients, including HCV, HIV, and CMV. She has also been involved in clinical trials related to new antimicrobial agents, especially antivirals. She is a former chair of the OPTN/UNOS Ad Hoc Disease Transmission Advisory Committee and has been extensively involved in the development of guidelines for the prevention of donor derived infections. She is a Consulting Editor for the American Journal of Transplantation and an Associate Editor for Transplant Infectious Diseases, President of the American Society for Transplantation, co-chair of the US Health and Human Services Advisory Committee on Blood and Tissue Safety and Availability, and Chair of the IDSA Training Program Directors Committee.

Dr. Deepali Kumar,MD, MSc, FRCP(C)

Professor of Medicine, University of Toronto

Deepali Kumar

Dr. Deepali Kumar is Professor of Medicine at the University of Toronto. She is attending physician in the Multi-Organ Transplant Program, Transplant Infectious Diseases service at University Health Network. She obtained her medical degree from the University of Ottawa and did infectious disease training at the University of California-San Diego and McMaster University. She further did a Masters degree with a focus in transplantation at the University of Toronto.

Dr. Kumar has a translational research program that consists of both clinical and laboratory-based research. Her research focuses on immunologic responses to viral infections and vaccines in transplant recipients. She has supervised numerous graduate students and medical residents/fellows. She has authored over 150 manuscripts, editorials, and book chapters in the field of transplantation. For her research she has been a recipient of the American Society of Transplantation Clinical Investigator Award (2018) and the Royal College Gold Medal in Medicine (2010). She is Editor-in-chief of The AST Handbook of Transplant Infections and Associate Editor of the 4th AST Transplant ID Guidelines.

Dr. Samir M. Parikh, MD, FASN

Harvard Medical School/Beth Israel Deaconess

Samir M. Parikh

Dr. Parikh is Associate Professor of Medicine at Harvard Medical School and staff physician in the Division of Nephrology at Beth Israel Deaconess Medical Center. His research is focused on molecular mechanisms underlying acute kidney injury and sepsis. In recent studies, the Parikh laboratory has explored the molecular basis of tubule pathology in sepsis, implicating mitochondrial biogenesis via PGC1 and NAD+ as a novel pathway for recovery from AKI. Ongoing studies are examining mechanistic links between AKI, CKD, and aging. Work from his team has been published in Nature, Nature Medicine, JCI, Science Translational Medicine and other high-impact journals. Dr. Parikh graduated magna cum laude from Harvard with a degree in chemistry and received the Founder’s Medal from Vanderbilt University School of Medicine. He completed post-graduate medical training at Beth Israel Deaconess Medical Center and Harvard Medical School. Dr. Parikh has served as principal investigator on research grants from the National Institutes of Health, American Society of Nephrology, American Heart Association, and American Diabetes Association. He is an elected member of the American Society of Clinical Investigation and the Interurban Clinical Club.

Dr. Cristiano Quintini,MD

Director of Liver Transplantation, Cleveland Clinic

Cristiano Quintini

Cristiano Quintini, MD, is the Director of Liver Transplantation at Cleveland Clinic. He is also a Staff Physician in Liver Transplantation and Hepatobiliary Surgery in the Department of General Surgery. Dr. Quintini area of expertize embrace complex liver surgery including advanced liver surgery for tumors (open and laparoscopic), living donor liver transplantation and liver transplantation. He is involved in clinical research in the field of liver surgery and transplantation as well as ex-vivo organ perfusion.

Dr. Quintini received his medical degree from the University of Bologna in Bologna, Italy. He completed a residency in the General Surgery Residency Program at University of Modena in Modena, Italy. Dr. Quintini then received an ASTS Fellowship from the University of Miami in abdominal transplant surgery, which he completed at Jackson Memorial Hospital in Miami, Fla. Dr. Quintini then completed an advanced fellowship in living donor liver transplantation, which he received from Cleveland Clinic in Cleveland, Ohio.

Dr. Alp Sener, MD, PhD, FRCSC


Alp Sener

Dr. Alp Sener completed his Urology residency at the Western University, London, Ontario, Canada in 2007 and then spent two years at the University of Maryland Medical Center in Baltimore as the American Society of Transplant Surgeons/Novartis Fellow in Transplantation. While in Maryland, he was trained in kidney, liver and pancreas transplantation followed by a post-doctoral fellowship in transplant immunology. Dr. Sener joined the Division of Urology at Western University in 2009 as the first Schulich Surgeon Scientist. He has been the recipient of local, national and international research contribution awards including the Western University Dean’s Award of Excellence, the Canadian Society of Transplantation Research Excellence Award and the Vanguard Award from the American Society of Transplant Surgeons. He currently serves as the Chair of Urology at Western University and is the President of the Urological Society of Transplant and Renal Surgeons (USTRS). In addition to a general urology and kidney/pancreas transplant directed clinical practice, Dr. Sener maintains an active basic sciences and translational research laboratory focusing on gasotransmitter biology and therapeutics. He has published over 90 peer-reviewed articles and 140 conference abstracts throughout his career. His laboratory pioneered the use of hydrogen sulphide in mitigating organ injury associated with transplantation, in modulating neovascularization and metastasis of renal cell carcinoma cell lines and in mitigating tissue fibrosis following chronic urinary obstruction. Dr. Sener continues to be heavily involved in promoting research and education through active roles on several national and international Urology (USTRS, American Urological Association and Canadian Urological Association) and Transplant (CST and American Society of Transplant Surgeons) committees and organizations.

Dr. David N. Rush, MD, FRCPC, FACP, 

Professor, Rady Faculty of Health Sciences, Max Rady College of Medicine
Section of Nephrology, University of Manitoba
Director, Transplant Manitoba – Adult Kidney Program
Winnipeg, Manitoba
David N. Rush

David Rush received his M.D. in 1972 from the National University of Tucumán, Argentina. His post-graduate training in Internal Medicine and Nephrology was undertaken at the University of Western Ontario in London. In 1982, he was recruited to the University of Manitoba in Winnipeg. In addition to several teaching awards, he was awarded the Canadian Society of Transplantation Lifetime Achievement Award in 2008, the Founders Award by The Kidney Foundation of Canada Manitoba Branch in 2013, The Kidney Foundation of Canada Medal of Research Excellence in 2015, and the Distinguished Service Award by Doctors Manitoba in 2016. He served as Head of the Section of Nephrology at the University of Manitoba from 1998 until July 2013. He is currently Professor of Medicine at the University of Manitoba, and Director of Transplant Manitoba–Adult Kidney Program. He is the author or co-author of 175 original publications, over 220 abstracts and posters, and six textbook chapters. His interests are clinico/pathological correlations in acute and chronic renal allograft rejection, non-invasive monitoring of the renal allograft and biomarker development, as well as medical education.

Dr. Scott Davis

Assistant Professor

Transplant Nephrology

Division of Renal Diseases & Hypertension

University of Colorado

Scott Davis

Scott Davis is a Transplant Nephrologist and an Assistant Professor of Medicine at University of Colorado. He grew up in the Pacific Northwest before attending Pitzer College, graduating with a Bachelor of Arts magna cum laude in Religious Studies. He was awarded the Freeman Foundation Asia Fellowship and studied the application of Buddhist philosophy to social and environmental movements in Thailand. After working with a mobile AIDS clinic in northern Thailand, he returned to the United States and completed a Bachelor of Science summa cum laude at Portland State University and medical school at Oregon Health and Science University, whereupon he moved to Colorado for medicine residency, nephrology, and transplant fellowships at the University of Colorado. In addition to clinical practice, he is director of the medical student renal pathophysiology course and regularly lectures and teaches residents and fellows. Dr. Davis is actively engaged in clinical research with publications in peer reviewed journals and he serves on the medical advisory board for Donor Alliance. He also enjoys road biking in the Colorado mountains and spending time with his wife and two young daughters.

Dr. Mark Haas

Department of Pathology & Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California USA
Mark Haas

Mark Haas is a renal pathologist at Cedars-Sinai Medical Center in Los Angeles, CA, and Professor of Pathology, Cedars-Sinai Professorial Series. A past president of the Renal Pathology Society and the 2012 recipient of its Jacob Churg Award for outstanding contributions in renal pathology, he has served on the Program Committee for the last six Banff Conferences on Allograft Pathology, chairing this Committee for the 2013 Banff Conference. He is an Associate Editor of The American Journal of Transplantation, a member of the Editorial Boards of Kidney International, Journal of the American Society of Nephrology and Clinical Nephrology, and a member of the International Editorial Advisory Board of Histopathology. His main interests include renal transplant pathology and glomerular diseases, particularly IgA nephropathy.

Dr. Anthony J. Demetris, MD

Anthony J. Demetris

Dr. Anthony Demetris is currently the Endowed Chair and the Starzl Professor of Liver and Transplant Pathology in the Department of Pathology at the University of Pittsburgh. He is also the Director of the Division of Transplantation Pathology and of the Research Histology Shared Research Laboratory, both at the University of Pittsburgh Medical Center. Dr. Demetris joined the University of Pittsburgh School of Medicine in 1986 after attending medical school and completing his residency at the University of Pittsburgh Medical Center in the Department of Pathology.

In addition to his academic positions, Dr. Demetris is actively involved in clinical research. Dr. Demetris’ primary research interests lie in:

  • the immunobiology of tolerance induction and chronic rejection
  • the role of cytokines in growth control of biliary epithelium
  • digital pathology for enhancing transplantation pathology and research

Since his appointment with the University, he has authored numerous publications, as well as making over 200 national/international presentations.

Dr. Demetris serves as the Co-chairman, Banff Conference on Allograft Pathology and the Chairman of the Liver Working Group, a member of the Editorial Boards of Current Opinion in Organ Transplantation, Digestive and Liver Disease, and American Journal of Transplantation an Abstract Review Board Member of the United States and Canadian Academy of Pathology, Inc., and the Director of the Liver and Kidney Tissue Core of the Immune Tolerance Network.

View a list of Dr. Demetris’ publications here.

Dr. Ben Adam

Assistant Professor, Department of Laboratory Medicine and Pathology, University of Alberta
Ben Adam

Dr. Adam is an Anatomical Pathologist and Assistant Professor at the University of Alberta. He completed medical school and residency training in Anatomical Pathology at the University of Alberta, followed by subspecialty training in Renal Pathology at Massachusetts General Hospital, Thoracic Pathology at Toronto General Hospital, and Transplantation Pathology at the University of Pittsburgh Medical Center. His research is focused on molecular transplantation pathology, including the use of cutting-edge gene expression technologies to diagnose and assess allograft rejection, infection, and ex vivo perfusion-related injury and repair. He has authored over 20 peer-reviewed journal articles and traveled throughout the world to present and lecture on the topics of his research. In 2015, he received the American Transplant Congress Young Investigator Award for his work.

Dr. Marie-Chantal Fortin,M.D., Ph.D., F.R.C.P.(c)

Nephrologist at the Centre hospitalier de l'Université de Montréal

Researcher at the Centre de recherche du CHUM

Associate Professor, Faculty of Medicine, Université de Montréal

Co-lead of the Patient Researcher Partnership Platform, Canadian Donation and Transplantation Research Program

Marie-Chantal Fortin

Marie-Chantal Fortin, M.D., Ph.D., F.R.C.P.(c) is a transplant nephrologist at the Centre hospitalier de l’Université de Montréal (CHUM), a researcher at the Research Center of the CHUM and an associate professor at the Faculty of Medicine of the Université de Montréal. She received her medical degree from the Université de Sherbrooke. She completed her nephrology residency at the Université de Montréal. She has completed a PhD in bioethics in 2008 at the Université de Montréal.

She is also a researcher within the Canadian Donation and Transplantation Research Program (CDTRP) and the co-leader of the Patient-Researcher Partnership Platform. Her research interests are related to transplantation ethics and patient and researcher partnership in research and clinical care. She chairs the ethics committee of the Canadian Society of Transplantation and she is a member of the ethics committee of Transplant Québec, the Canadian Blood Services and the Collège des médecins du Québec. Finally, she is also a research scholar of the FRQS.

Dr. Rahul Mainra,MD FRCPC FRACP MMed

Director of Undergraduate Medical Education, Department of Medicine

Clinical Associate Professor of Medicine, Division of Nephrology

Room B2.25 St. Paul’s Hospital

Rahul Mainra

Dr. Rahul Mainra is a Transplant Nephrologist working in the Division of Nephrology at St. Paul’s Hospital in Saskatoon, Saskatchewan. He completed his medical training and residency in Saskatoon followed by a Nephrology fellowship at Western University in London, Ontario. Following this, he spent a year in Sydney, Australia completing a transplant fellowship along with a Masters in Medicine at the University of Sydney Department of Clinical Epidemiology. He returned to Saskatoon in 2008 to join the Saskatchewan Transplant Program in his current role. Rahul is active in the undergraduate medical program at the University of Saskatchewan and is the director of UGME for the Department of Medicine. Nationally, he is involved in various working groups within CBS and is co-chair of the Kidney Transplant Advisory Committee.